about
Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry.Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic RegistriesTemporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry.Coronary artery disease: new insights into the pathophysiology, prevalence, and early detection of a monster menace.Diagnostic Accuracy of Cardiac Magnetic Resonance Imaging in the Evaluation of Newly Diagnosed Heart Failure With Reduced Left Ventricular Ejection Fraction.Quantitative Perfusion Analysis of First-Pass Contrast Enhancement Kinetics: Application to MRI of Myocardial Perfusion in Coronary Artery Disease.Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease.Radiation exposure during coronary angiography via transradial or transfemoral approaches when performed by experienced operators.Use of real time three-dimensional transesophageal echocardiography in intracardiac catheter based interventions.Effectiveness of fluorography versus cineangiography at reducing radiation exposure during diagnostic coronary angiography.Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.Evaluating patent ductus arteriosus during percutaneous closure: correlation between intravascular ultrasonography and computed tomographic angiography.Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes.The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.Effect of Left Versus Right Radial Artery Approach for Coronary Angiography on Radiation Parameters in Patients With Predictors of Transradial Access Failure.Dual source computed tomography coronary angiography in new onset cardiomyopathy.Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry.Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.Discrete atherosclerotic coronary artery aneurysms: a study of 20 patients.A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention.Transesophageal echocardiography in the diagnosis of ostial left coronary artery stenosis.Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy.Response to letter regarding article, “Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison Analysis of 117,762 patient-years of follow-up from randomized trials”.Echocardiographic predictors of single versus dual MitraClip device implantation and long-term reduction of mitral regurgitation after percutaneous repair.Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention.3D transesophageal echocardiography and radiography of mitral valve prostheses and repairs.Association between diet quality and measures of body adiposity using the Rate Your Plate survey in patients presenting for coronary angiography.Percutaneous PFO closure for the prevention of recurrent brain abscess.Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomy.Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.Multimodality Imaging of Bioprosthetic Percutaneous Balloon Valvuloplasty Followed by Valve-in-Valve Implantation for Mitral Stenosis Due to Commissural Leaflet Fusion.Characteristics of plaque disruption by intravascular ultrasound in women presenting with myocardial infarction without obstructive coronary artery disease.The Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial: study design and rationale.Comparison of cardiac catheterization and Doppler echocardiography in the decision to operate in aortic and mitral valve disease.Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry.Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?Posterior Descending Coronary Artery Arising From a Septal Branch of the Left Anterior Descending Coronary Artery.
P50
Q31108661-5381ED5A-3B4D-4807-8A23-C810EBA07352Q33600990-35A0C7FC-A188-44E2-9003-2BC7F6EF4B10Q33872047-8F8C76DB-07F0-43E8-8923-685BDA65D316Q34505408-EF34AD82-4229-45F8-8571-FC879C2D9216Q34541968-1DA652D2-6F58-4261-8B2F-A15ABE9ABB8DQ35782459-6DD91AF7-11D4-4DAB-A04C-D91E925743D7Q36054409-C959DD9B-B3DA-4B85-A948-3DE91F5F6D0DQ36119540-C196F6C2-802D-4B50-B97B-D6FC28B85308Q36154232-7526F31C-C80D-4D98-909D-CE3F8573DADFQ36747886-68FE5C87-1922-4D26-ADC9-D912E6CCFB03Q37070194-DC3E9D8D-151B-43F9-8A7F-2466668C1CD9Q37568757-26D3A4D2-0449-411A-8060-33D43B761B83Q37646817-200CDB1A-078A-4B68-99FC-35E25AC528F4Q38492894-A9B501CB-C350-4139-B66F-378F88AEE3C5Q39053885-83E0E7E0-BB00-4D3B-9163-535049F9BD51Q39947537-9FC44049-3B07-454D-AA57-4FCDBA285330Q40101721-4EE2D2FD-B743-408E-9526-29E4710A987FQ40689201-997F03B5-C761-462B-9737-F3431C7BCD8AQ42228756-29146FB8-2994-4A02-9119-34427693BAE6Q43772549-21E54DAE-6438-4837-85A4-0190A2691C85Q43824509-41B2409A-0F0D-4ED0-9A74-AD1C155E3D32Q43829873-4DD69E79-377B-4510-AE1A-31E67108CAE0Q44397616-F02F2F10-D55D-480E-B223-C51BB5643C1CQ44663690-F305710F-8383-42BB-8EB4-D8DE1B6F1535Q44703483-74B3F482-FAA2-48AB-8BC8-88B0B1CDBEF7Q45129380-D4DCF210-AAB6-49C0-BED0-27B9EFE3A78DQ46473023-C024F4C0-4588-4FE9-A6C7-FD66784908F2Q46947291-095B5424-F1B5-4366-9E10-C857319653ADQ47788285-884FB94D-D316-40A4-A30D-E92815CDD610Q48246547-7316AF5F-7131-4048-BF2F-CBFF019F3C63Q48378060-6D2ADF0A-67B5-45E7-A9B5-ACDDD43BA9B3Q50763806-FB5CD90B-0E7B-48D4-AC64-96A5CE6431A7Q50901497-6FECFDCE-4333-43D0-BE2E-35DC23EE57CEQ51508333-374A3780-82C9-4272-BAC6-A85879DA5CBCQ52649679-80363E22-AB86-4491-8745-8F9FE18AC172Q52716318-25073347-6BE4-439A-819F-9A58A3C9AC12Q52864191-65E77899-F1F7-4CE4-B92F-A82DB407919EQ52931755-98201C02-1031-4AC4-9687-6A38DD272C36Q53333033-30A5F6E4-5197-440E-9616-6392A3B2513CQ53535138-5E45F493-63C4-4577-BF35-268F239DAAA1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
James Slater
@ast
James Slater
@en
James Slater
@es
James Slater
@nl
James Slater
@sl
type
label
James Slater
@ast
James Slater
@en
James Slater
@es
James Slater
@nl
James Slater
@sl
prefLabel
James Slater
@ast
James Slater
@en
James Slater
@es
James Slater
@nl
James Slater
@sl
P106
P21
P31
P496
0000-0003-3888-0317